Abstract:OBJECTIVE:To evaluate the bioequivalence of two kinds of isosorbide mononitrate sustained tablets in Chinese healthy volunteers.METHODS:According to two formulas double period crossover protocol,a total of 18 healthy volunteers were orally administered with test prepartion(T)or reference preparation(R)(40mg),1w later,they were administered with R or T by a crossover way.For multidoese trial,the patients received T or R 40mg every morning for 6 consecutive days.Blood samples were taken at 4-6 days before oral administration in the morning,and according to the protocal,the blood samples were taken at 6d after oral administration.Serum concentrations of isosorbide mononitrate were measured with validated GC-ECD.The pharmacokinetic parameters and bioavailability of two isosorbide mononitrate sustained tablets were calculated and the bioequivalence was evaluated.RESULTS:The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with an oral single dose of 40mg were as follows:T max(4.9±1.6)and(4.9±1.2)h,C max(719.42±183.72)and(726.52±177.55)ng·mL-1,t_ 1/2(3.9±0.6)and(3.7±0.9)h,AUC_ 0-t(5 687.38±1 271.64)and(5 586.05±1 290.01)ng·h·mL-1,AUC_ 0-∞(5 831.67± 1 308.47)and(5 719.20±1 329.54)ng·h·mL-1,and computed based on AUC_ 0-t,the relative bioavailability of tested isosorbide mononitrate sustained tablet was(103.0±17.1)%.The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with oral multi-dose of 40 mg were as follows:T max-ss(4.9±1.4)and(4.9±1.5)h,C max-ss(745.43±143.83)and(747.55±130.72)ng·mL-1,AUC ss(7 860.24± 1 827.46)and(8 104.13±1 637.35)ng·h·mL-1,and the relative bioavailability of tested isosorbide mononitrate sustained tablet was(97.1±10.9)%.Tested with Wilcoxon(T max),ANOVA and two one-sided t test(AUC,C max),the main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablets showed no significant differences.The 90% confidential intervals of C max and AUC_ 0-t of tested formula were 93.26%～104.33% and 95.10%～108.83%,respectively.The 90% confidential intervals of C max-ss and AUC ss of tested formula were 93.97%～105.01% and 92.24%～101.08%,respectively.CONCLUSION:Two kinds of isosorbide mononitrate sustained tablets are bioequivalent.

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Study of bioequivalence of compound metformin hydrochloride tablet in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Pharmacokinetics and bioequivalance of domestic compound glibenclamide and metformin in chinese healthy volunteers

Bioequivalence and Pharmacokinetic Evaluation of Two Metformin Hydrochloride Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Relative Bioavailability and Bioequivalence of Metforphin Hydrochloride Extended-Released and Immediate-Released Tablets in Healthy Chinese Volunteers

Post-Marketing Reevaluation of Bioequivalénce of Metformin Hydrochloride Enteric-Coated Tablets

Pharmacokinetics and relative bioavailability of compound metformin hydrochloride tablet in healthy volunteers

Pharmacokinetics and Bioequivalence of Compound Mefformin Hydrochloride Tablets in Healthy Volunteers

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

Bioequivalence of trimetazidine dihydrochloride tablets in Chinese healthy subjects

Post-Marketing Reevaluation on Bioequivalence of Metformin Hydrochloride Tablets

Bioequivalence of Glipizide Controlled-Release Tablets in Chinese Healthy Volunteers

Study of the Bioequivalence of Gliclazide in Chinese Healthy Volunteers

Bioequivalence and Safety Assessment of Two Formulations of Metformin Hydrochloride Sustained-Release Tablets (Yuantang® SR and Glucophage® XR) Under Fed Conditions in Healthy Chinese Adult Subjects: An Open-Label, Two-Way Crossover, Sequence Randomized Phase I Clinical Trial

Bioequivalence and Safety Assessment of 2 Formulations of Low‐Dose Metformin Hydrochloride under Fasting Conditions in Healthy Chinese Participants: A Randomized Phase I Clinical Trial

Bioequivalence of Isosorbide Mononitrate Sustained Tablets in Chinese Healthy Volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Pharmacokinetics and Comparative Bioavailability of Two Metformin Formulations after Single-Dose Administration in Healthy Subjects

Bioequivalence Study of Two Esomeprazole Enteric Coated Formulations in Healthy Chinese Volunteers